KUWAIT DRUGS

 

SEARCH

 

SUGGESTIONS

 

ADD PRODUCTS

 

HOME

0-9    A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

 

 

PREVIOUS

  

NEXT

 
 

SELEXID 200 MG TABLETS

 

 
 

 

GENERIC NAMES

MANUFACTURERS 

MEDICAL GROUP

MEDICAL ARTICLES

 

DRUGS IN :

 

 

FDA DRUGS

UNITED STATES

CANADA

UNITED KINGDOM

AUSTRALIA

GERMANY

FRANCE

MIDDLE EAST

KUWAIT

LEBANON

EGYPT

SYRIA

BAHRAIN

IRAN

JORDAN

SAUDI ARABIA

UNITED ARAB EMIRATES

 

 

 
 

SIZE:

200 MG

 

GENERIC NAME:

PIVMECILLINAM

 

MANUFACTURER:

LEO PHARMACEUTICAL PRODUCTS

 

UNIT:

 

ADMINISTRATION ROUTE:

 

FDA PREGNANCY GROUP:

B

 

INDICATIONS:

 

SIDE EFFECTS:

Allergic reactions, specifically anaphylaxis

exfoliative dermatitis

serum sickness-like reactions

skin rash, hives, or itching

Clostridium difficile colitis

hepatotoxicity

interstitial nephritis

leukopenia or neutropenia

mental disturbances

pain at site of injection

platelet dysfunction or thrombocytopenia

seizures

Gastrointestinal reactions

headache

oral candidiasis

vaginal candidiasis

 

ABSOLUTE CONTRAINDICATIONS :

 

RELATIVE CONTRAINDICATIONS :

Allergy, general, history of sensitivity to multiple allergens

>> Bleeding disorders

Carnitine deficiency

>> Congestive heart failure

Hypertension

>> Cystic fibrosis

>> Gastrointestinal disease, history of, especially antibiotic-associated colitis

>> Mononucleosis, infectious

>> Phenylketonuria

>> Renal function impairment

 

ADULT DOSE:

Antibacterial- Oral, 200 mg two to four times a day for three days.

 

MAXIMUM ADULT DOSE:

 

PEDIATRIC DOSE:

Antibacterial- Children up to 40 kg of body weight: Dosage has not been established. Children 40 kg of body weight and over: See Usual adult and adolescent dose. 

 

MAXIMUM PEDIATRIC DOSE:

 

ELDERLY DOSE:

 

 

PREVIOUS

  

NEXT